Debby den Uyl
Affiliation: VU University Medical Center
Country: The Netherlands
- Glucocorticoid-induced osteoporosisD den Uyl
VU University Medical Center, Department of Rheumatology, 1081 HV Amsterdam, The Netherlands
Clin Exp Rheumatol 29:S93-8. 2011..Different treatment options are summarised considering the pathogenesis of glucocorticoid-induced osteoporosis. Improved insights into pathogenesis might result in development of new treatment possibilities...
- Advances in glucocorticoid-induced osteoporosisDebby den Uyl
Department of Rheumatology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
Curr Rheumatol Rep 13:233-40. 2011....
- (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosisDebby den Uyl
Department of Rheumatology, VU Medical Centre, De Boelelaan 1117, 1081 NV Amsterdam, The Netherlands
Arthritis Res Ther 13:R5. 2011..The co-occurrence of cardiovascular disease and osteoporosis prompted us to review the evidence of an association between cardiovascular (CV) disease and osteoporosis and potential shared common pathophysiological mechanisms...
- Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reductionDebby den Uyl
VU University Medical Center, Amsterdam, The Netherlands
Arthritis Rheum 64:639-46. 2012..To investigate the dose-related effects of glucocorticoid treatment on glucose tolerance, beta cell function, and insulin sensitivity in patients with early active rheumatoid arthritis (RA)...
- Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trialDebby den Uyl
Department of Rheumatology, VU Medical Centre, Room 3A58, P O Box 7057, 1007 MB, Amsterdam, The Netherlands
Clin Rheumatol 29:465-72. 2010..A significant greater number of patients considered the chewable tablet as preferable and acceptable to the sachet, containing calcium and vitamin D(3). TRIAL REGISTRATION: Current Controlled Trials ISRCTN18822358...
- Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with Sue Ellen Verbrugge
Department of Rheumatology, VU Institute for Cancer and Immunology, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
J Pharmacol Exp Ther 341:174-82. 2012..These results indicate that the pharmacologic activity of these PIs may be hindered by drug resistance mechanisms involving PSMB5 mutations and PI extrusion via Pgp...